A local coverage determination (LCD) is the regional Medicare policy that decides whether your debridement or skin substitute application gets paid, and it can differ depending on which Medicare Administrative Contractor (MAC) covers your state. For a wound care practice, that means the same CTP application reimbursed without question in one jurisdiction might trigger a denial letter in the next state over. Understanding how LCDs work, how they interact with national policy, and how to document against both is now a core part of running a defensible wound care practice.
What Counts as a Local Coverage Determination?
Medicare coverage policy operates on two levels. A National Coverage Determination (NCD) comes directly from CMS and applies uniformly across the country. A local coverage determination (LCD), by contrast, is written and maintained by one of the Medicare Administrative Contractors (MACs) that CMS contracts with to process claims in a defined geographic jurisdiction. Where an NCD exists, it takes precedence, and an LCD may not restrict coverage for a service the NCD explicitly covers. For most of the services wound care clinicians bill every day, however, no NCD exists, and coverage rules are set at the MAC level.
An LCD spells out the specific conditions under which a service will be considered medically necessary. That typically includes the diagnoses that qualify, the frequency at which a procedure can be repeated, the clinical documentation a chart must contain, and sometimes explicit exclusions. For a debridement code, for instance, an LCD might require documentation of wound progress before allowing another billed session within a certain interval. For a skin substitute, it might specify a minimum duration of standard wound care that must fail first.
LCDs are not static. MACs revise them periodically to reflect new evidence, coding changes, or CMS guidance, and they can retire or withdraw an LCD altogether. Every current and historical LCD, along with draft versions open for public comment, is searchable in the CMS Medicare Coverage Database, which remains the authoritative source for confirming what a given MAC currently requires. Relying on a printout from a few years ago, or on a colleague’s description of “the rule,” is one of the more common ways practices end up out of compliance without realizing it.
Which Wound Care Services Draw the Most Coverage Scrutiny?
Three service categories draw the most coverage scrutiny in wound care, and each carries its own audit risk profile.
Skin Substitutes
Skin substitutes, more accurately called cellular and/or tissue-based products (CTPs), are the most heavily scrutinized products in the specialty. Where CTP LCDs exist, they commonly require at least four weeks of documented, failed conservative care before a CTP application is considered necessary, and they cap the number of applications per wound within a given period. The coverage landscape is also unusually unsettled. Identical CTP LCDs finalized by all of the A/B MACs were withdrawn by CMS on December 24, 2025, days before they were to take effect. As a result, only Novitas, First Coast, and CGS currently have active skin substitute LCDs; in the other jurisdictions, claims are judged case by case against the “reasonable and necessary” standard. Meanwhile, the CY 2026 Physician Fee Schedule moved most skin substitutes to a single national payment rate of roughly $127 per square centimeter, and CMS has reopened its call for clinical evidence on skin substitutes. With or without an LCD, Medicare audits of CTP use continue, and documented data on healing rates and application counts is increasingly what separates a defensible claim from a denied one.
2. Debridement
Debridement, whether surgical, selective, or non-selective, is addressed in wound care LCDs such as Novitas’, with logic built around frequency and progress. Because these codes can be billed repeatedly over the life of a chronic wound, MACs want to see that each subsequent procedure is justified by documented, ongoing need rather than routine habit. A chart that shows a wound plateauing without any explanation, or without adjustment to the treatment plan, is a natural denial target, and debridement has a long history as a MAC audit focus.
3. HBOT
Hyperbaric oxygen therapy is different: its covered conditions are set nationally by NCD 20.29, not by LCDs. For diabetic foot ulcers, the NCD requires a lower-extremity wound due to type 1 or type 2 diabetes, classified as Wagner grade III or higher, that has shown no measurable signs of healing after at least 30 days of standard wound therapy. MACs cannot narrow that coverage, but they can issue supplemental guidance and documentation requirements that go beyond the NCD. HBOT documentation that skips the 30-day failure narrative, or that doesn’t clearly tie the qualifying diagnosis to the wound being treated, is a frequent audit finding. Because HBOT is resource-intensive and closely watched by payers, hyperbaric physicians in particular should treat the NCD and their MAC’s guidance as a documentation checklist rather than background policy.
How Do LCDs Change Documentation Requirements for Clinicians?
LCDs don’t just say what’s covered; they specify how you have to prove it. Most wound-related LCDs expect objective measurements (wound size, depth, tissue type, and percent granulation) recorded at defined intervals rather than described in general terms. “Improving” is not a data point a MAC reviewer can act on; a wound that measured 4.2 by 3.1 centimeters two weeks ago and 3.6 by 2.8 centimeters today is.
Three documentation gaps come up again and again in wound care denials and audits:
- Missing or incomplete prior-treatment history, so the record doesn’t show the required period of standard care before a CTP application or HBOT referral
- No vascular workup on file before debridement or CTP use on a lower-extremity wound, even though many LCDs expect arterial status to be assessed and documented, often with an ankle-brachial index
- Comorbidities affecting healing, such as uncontrolled diabetes or peripheral arterial disease, mentioned in the problem list but never connected to the wound care plan in the visit note
A structured wound registry that captures these fields at the point of care, rather than relying on free-text narrative, changes the economics of compliance. Instead of a nurse or medical director reconstructing a chart from memory when a MAC requests records, the data already exists in a queryable format. This is where wound care charting built for the specialty, rather than adapted from a general EHR template, pays off: fields for wound measurements, tissue type, and prior treatment duration become mandatory parts of the visit rather than optional narrative a busy clinician might skip.
Why Does Coverage Vary by MAC Jurisdiction?
CMS divides the country into 12 A/B MAC jurisdictions, served by contractors including Novitas, First Coast, Palmetto GBA, National Government Services (NGS), CGS Administrators, WPS, and Noridian, each responsible for processing Part A and Part B claims within its assigned states. Because each MAC drafts and maintains its own LCDs, two practices treating clinically identical diabetic foot ulcers in neighboring states can face different documentation burdens, different application limits, or in some cases, different coverage outcomes entirely for the same product or procedure. Skin substitutes are the clearest current example: a CTP application governed by a detailed LCD in a Novitas state is judged case by case in a neighboring state with no active LCD.
This matters most acutely for multi-site wound center groups and management companies operating across state lines. A CTP indication that one jurisdiction’s LCD covers with standard documentation might require additional supporting evidence, or be excluded outright, under a neighboring MAC’s policy. Administrators building roster-wide protocols need to know that a single national training deck on “how we document skin substitute use” may not hold up uniformly across every site in the network.
The practical takeaway is straightforward: identify which MAC has jurisdiction over each of your billing locations, and monitor that contractor’s LCD list specifically rather than assuming a single national standard governs your specialty. The CMS Medicare Coverage Database allows searches filtered by contractor and by state, which makes this a manageable task once it’s built into a routine rather than something checked only after a denial arrives.
How Can Registry Data Influence Coverage Policy?
LCDs are not handed down in a vacuum. MACs periodically reconsider policy language, and they draw on the evidence available to them when doing so. Clinical trials in wound care frequently exclude the sickest, most comorbid patients, the exact population that fills hospital outpatient wound centers and SNF caseloads. That leaves a gap between what trial data shows and what clinicians actually see, and it’s a gap that aggregated, risk-adjusted registry data is uniquely positioned to fill.
Wound care registries that collect structured, de-identified data across thousands of patients and provider sites can generate wound healing rate benchmarks, diabetic foot ulcer and venous leg ulcer outcomes, and CTP utilization patterns that reflect real-world practice rather than a narrow trial cohort. When CMS or a MAC proposes tightening or cutting coverage or payment for a wound care service, that kind of real-world evidence gives specialty organizations something concrete to bring to the comment period, rather than anecdote alone. There is precedent: when CMS proposed basing hospital outpatient wound care facility payment on wound size categories, the Alliance of Wound Care Stakeholders presented Intellicure registry data showing that most chronic wounds are relatively small, so size could not differentiate the complexity of care. It’s an example of how organized specialty data can shape the policy conversation rather than simply react to it.
This is the underlying case for participating in a qualified clinical data registry (QCDR): it earns MIPS credit through measures actually built for wound care and podiatry rather than measures borrowed from other specialties (the US Wound Registry’s QCDR measures were developed jointly with the Alliance of Wound Care Stakeholders), and it contributes to the pooled evidence base available when a coverage or payment policy comes up for reconsideration. Every practice that reports structured, risk-adjusted outcomes data adds weight to that evidence base. For a specialty that faces recurring reimbursement threats, that combination (penalty avoidance now and a stronger data record for the next policy fight) is hard to get from any other single workflow change.
Where Should You Monitor LCD Updates?
LCDs change without much individual outreach to affected practices, so monitoring has to be a deliberate, recurring task rather than something triggered by a denial. Intellicure monitors LCDs for its users, and updates its templates accordingly, so if you don’t have Intellicure, try instituting these 3 habits:
- Check the CMS Medicare Coverage Database directly for your MAC’s active and draft LCDs on wound care, debridement, and CTPs, along with NCD 20.29 and any MAC guidance on HBOT. Set a recurring calendar reminder (quarterly is reasonable), since revisions often carry limited advance notice.
- Follow your specific MAC’s provider bulletins and listserv, along with the Alliance of Wound Care Stakeholders, which tracks specialty-specific policy changes and flags draft LCD comment periods when clinician input can still shape the outcome.
- Build LCD-required data fields (wound measurements, tissue type, prior treatment duration, and vascular workup status) directly into EHR templates or registry intake forms so the documentation exists prospectively rather than needing reconstruction after an audit letter arrives.
That last point is the one most practices underinvest in. Reviewing policy is necessary but not sufficient; the chart has to reflect the policy at the moment of care, not after the fact.
Building Compliance into the Workflow, Not the Audit Response
LCDs will keep shifting by jurisdiction and by year, and no practice can treat a single policy review as permanent. The practices that stay ahead are the ones that build LCD-required documentation into everyday charting and registry participation, so compliance is a byproduct of normal clinical workflow rather than a scramble triggered by an audit letter. Start by confirming which MAC governs each of your billing locations, pulling that contractor’s current wound care LCDs, and checking whether your charting already captures what they require or needs new structured fields to get there. Or, simply switch your wound care EMR to Intellicure, which updates its templates and documentation processes to match LCD requirements as they come.
Recent Comments